UNSPSC 51263161: Cloranolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C13H19Cl2NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 79SQ2WFQ23, chemically known as (+/-)-dichlorophenoxy)-3-tert-butylamino-2-propanol hydrochloride, but more generally known as cloranolol hydrochloride, which bears US NIH Compound Identifier 162743. European Medicines Agency schedules cloranolol hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06752MIG.

Most nations, for tariff purposes, schedule cloranolol hydrochloride under HS 29221980. SMILES: CC(C)(C)NCC(COC1CC(CCC1CL)CL)O.CL.

UNSPSC 51263161 Cloranolol hydrochloride is a Commodity code that shows no relevant recent state and local procurement activity. The single opportunity posted under this code—Seminole County, Florida's IFB60459723LAS issued June 30, 2026—solicits naloxone and drug deactivation systems for community health delivery, a product category plainly unrelated to cloranolol hydrochloride, a pharmaceutical intermediate used in industrial synthesis. The mismatch suggests a tagging error in the source data rather than genuine market demand for this commodity among state and local buyers.

No state or local procurement body has posted a solicitation for cloranolol hydrochloride itself in the available record. Vendors evaluating this code should treat it as inactive for business development purposes and monitor related pharmaceutical and health-supply codes where state and local governments actually issue tenders.